Robert W. Baumhefner

732 total citations
23 papers, 525 citations indexed

About

Robert W. Baumhefner is a scholar working on Pathology and Forensic Medicine, Radiology, Nuclear Medicine and Imaging and Oncology. According to data from OpenAlex, Robert W. Baumhefner has authored 23 papers receiving a total of 525 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Pathology and Forensic Medicine, 11 papers in Radiology, Nuclear Medicine and Imaging and 7 papers in Oncology. Recurrent topics in Robert W. Baumhefner's work include Multiple Sclerosis Research Studies (11 papers), Monoclonal and Polyclonal Antibodies Research (9 papers) and Polyomavirus and related diseases (6 papers). Robert W. Baumhefner is often cited by papers focused on Multiple Sclerosis Research Studies (11 papers), Monoclonal and Polyclonal Antibodies Research (9 papers) and Polyomavirus and related diseases (6 papers). Robert W. Baumhefner collaborates with scholars based in United States, United Kingdom and Taiwan. Robert W. Baumhefner's co-authors include Wallace W. Tourtellotte, Karl Syndulko, Paul Shapshak, W. W. Tourtellotte, Alfred R. Potvin, Michael J. Walsh, Susan M. Staugaitis, Hansjürgen Agostini, Caroline F. Ryschkewitsch and G. L. Stoner and has published in prestigious journals such as Neurology, Annals of Neurology and Annals of the New York Academy of Sciences.

In The Last Decade

Robert W. Baumhefner

23 papers receiving 492 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Robert W. Baumhefner United States	14	283	149	147	76	69	23	525
Philipp Schwenkenbecher Germany	21	400 1.4×	125 0.8×	307 2.1×	117 1.5×	51 0.7×	56	902
Manuel Bartolomé Spain	14	262 0.9×	131 0.9×	74 0.5×	190 2.5×	11 0.2×	19	602
Peter Wipfler Austria	17	362 1.3×	166 1.1×	178 1.2×	168 2.2×	14 0.2×	56	658
Kaylan Fenton United States	9	216 0.8×	74 0.5×	66 0.4×	75 1.0×	48 0.7×	13	458
R. Roselli Italy	17	189 0.7×	165 1.1×	506 3.4×	11 0.1×	96 1.4×	37	1.1k
Marta García‐Montojo Spain	20	240 0.8×	214 1.4×	134 0.9×	183 2.4×	8 0.1×	41	1.0k
M. E. Boon Netherlands	16	123 0.4×	82 0.6×	103 0.7×	21 0.3×	37 0.5×	40	732
W. A. Sheremata United States	7	134 0.5×	36 0.2×	130 0.9×	125 1.6×	18 0.3×	8	592
Makbule Şenel Germany	20	635 2.2×	118 0.8×	420 2.9×	232 3.1×	158 2.3×	43	1.2k
Markus C. Kowarik Germany	15	483 1.7×	141 0.9×	289 2.0×	357 4.7×	60 0.9×	48	977

Countries citing papers authored by Robert W. Baumhefner

Since Specialization

Citations

This map shows the geographic impact of Robert W. Baumhefner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert W. Baumhefner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert W. Baumhefner more than expected).

Fields of papers citing papers by Robert W. Baumhefner

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert W. Baumhefner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert W. Baumhefner. The network helps show where Robert W. Baumhefner may publish in the future.

Co-authorship network of co-authors of Robert W. Baumhefner

This figure shows the co-authorship network connecting the top 25 collaborators of Robert W. Baumhefner. A scholar is included among the top collaborators of Robert W. Baumhefner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert W. Baumhefner. Robert W. Baumhefner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Baumhefner, Robert W. & Mei Leng. (2022). Standard Dose Weekly Intramuscular Beta Interferon-1a May Be Inadequate for Some Patients with Multiple Sclerosis: A 19-Year Clinical Experience Using Twice a Week Dosage. Neurology and Therapy. 11(3). 1399–1408. 2 indexed citations

LaRocca, Nicholas G., Labe C. Scheinberg, Robert J. Slater, et al.. (2009). Field testing of a minimal record of disability in multiple sclerosis: The United States and Canada. Acta Neurologica Scandinavica. 70(S101). 126–138. 8 indexed citations

Agostini, Hansjürgen, Caroline F. Ryschkewitsch, Robert W. Baumhefner, et al.. (2000). Influence of JC virus coding region genotype on risk of multiple sclerosis and progressive multifocal leukoencephalopathy.. PubMed. 6 Suppl 2. S101–8. 29 indexed citations

Agostini, Hansjürgen, Elyse J. Singer, Robert W. Baumhefner, et al.. (1998). JC virusType 2: definition of subtypes based on DNA sequence analysis of ten complete genomes.. Journal of General Virology. 79(5). 1143–1151. 41 indexed citations

Stoner, Gerald L., Hansjürgen Agostini, Caroline F. Ryschkewitsch, Robert W. Baumhefner, & Wallace W. Tourtellotte. (1996). Characterization of Jc Virus Dna Amplified from Urine of Chronic Progressive Multiple Sclerosis Patients. Multiple Sclerosis Journal. 1(4). 193–199. 25 indexed citations

Syndulko, Karl, et al.. (1996). Effects of Temperature in Multiple Sclerosis: A Review of the Literature. Neurorehabilitation and neural repair. 10(1). 23–34. 29 indexed citations

Syndulko, Karl, Der-Shin Ke, George W. Ellison, et al.. (1996). Comparative evaluations of neuroperformance and clinical outcome assessments in chronic progressive multiple sclerosis: I. reliability, validity and sensitivity to disease progression. Multiple Sclerosis Journal. 2(3). 142–156. 20 indexed citations

Syndulko, Karl, et al.. (1995). Preliminary Evaluation of Lowering Tympanic Temperature for the Symptomatic Treatment of Multiple Sclerosis. Neurorehabilitation and neural repair. 9(4). 205–215. 14 indexed citations

Conrad, Andrew, Edna Y. Chiang, Carlo Avolio, et al.. (1994). Quantitation of intrathecal measles virus IgG antibody synthesis rate: Subacute sclerosing panencephalitis and multiple sclerosis. Journal of Neuroimmunology. 54(1-2). 99–108. 35 indexed citations

10.

Baumhefner, Robert W.. (1990). Quantitative Multiple Sclerosis Plaque Assessment With Magnetic Resonance Imaging. Archives of Neurology. 47(1). 19–19. 61 indexed citations

11.

Baumhefner, Robert W., et al.. (1989). Multiple sclerosis intra-blood-brain-barrier IgG synthesis: effect of pulse intravenous and intrathecal corticosteroids. Neurological Sciences. 10(1). 19–32. 4 indexed citations

12.

Baumhefner, Robert W., et al.. (1988). Copolymer 1 as therapy for multiple sclerosis: the cons.. PubMed. 38(7 Suppl 2). 69–72. 8 indexed citations

13.

Tourtellotte, W. W., Robert W. Baumhefner, & Paul Shapshak. (1988). Measuring intra-BBB IgG synthesis rate by formula in multiple sclerosis. Journal of Neuroimmunology. 17(3). 262–262. 1 indexed citations

14.

Tourtellotte, W. W., Robert W. Baumhefner, Karl Syndulko, et al.. (1988). The long march of the cerebrospinal fluid profile indicative of clinical definite multiple sclerosis; and still marching. Journal of Neuroimmunology. 20(2-3). 217–227. 30 indexed citations

15.

Baumhefner, Robert W. & W. W. Tourtellotte. (1985). Cellular immunology in multiple sclerosis. A review through 1984.. PubMed. 2. 151–88. 1 indexed citations

16.

Tourtellotte, Wallace W., Susan M. Staugaitis, Michael J. Walsh, et al.. (1985). The basis of intra‐blood‐brain‐barrier IgG synthesis. Annals of Neurology. 17(1). 21–27. 78 indexed citations

17.

Tourtellotte, Wallace W., Michael J. Walsh, Robert W. Baumhefner, Susan M. Staugaitis, & Paul Shapshak. (1984). The Current Status of Multiple Sclerosis Intra‐Blood‐Brain‐Barrier IgG Synthesis. Annals of the New York Academy of Sciences. 436(1). 52–67. 38 indexed citations

18.

Tourtellotte, Wallace W., Alfred R. Potvin, Robert W. Baumhefner, et al.. (1982). Isotachophoresis quantitation of subtractions of multiple sclerosis intra‐blood‐brain barrier IgG synthesis modulated by ACTH and/or steroids. Neurology. 32(3). 261–261. 18 indexed citations

19.

Tourtellotte, Wallace W., Robert W. Baumhefner, Alfred R. Potvin, et al.. (1980). Multiple sclerosis de novo CNS IgG synthesis. Neurology. 30(11). 1155–1155. 51 indexed citations

20.

Tourtellotte, Wallace W., Alfred R. Potvin, Mario F. Mendez, et al.. (1980). Failure of intravenous and intrathecal cytarabine to modify central nervous system IgG synthesis in multiple sclerosis. Annals of Neurology. 8(4). 402–408. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact